Macroaggregated serum albumin (MAA) particles labeled with 131iodine (1311) or similar particles-labeled with 99mtechnetium (99mTc) or both types were injected directly into the coronary circulation of 29 patients at the time of conventional coronary arteriography. Radionuclide images of the distribution of these small (10-60 gu) biodegradable particles in the small vessels of the heart wall were made with a commercial Anger-type scintillation camera in much the same way as routine pulmonary perfusion scans are made. The resulting images depicted the relative regional distribution of blood flow to the myocardium in these patients suspected of having coronary artery disease. The myocardial perfusion images were of good quality and allowed gross assessment of perfusion by way of each major coronary artery. This was done by injecting 99mTc-labeled particles into the left coronary artery and 1311-MAA into the right coronary artery through the coronary artery catheter. Separate or composite images of the relative small vessel perfusion via each vessel injected were obtained by electronic pulse-height discrimination. No untoward reactions followed the intracoronary injection of the labeled particles. From our preliminary experience, we conclude that myocardial perfusion imaging in conjunction with coronary arteriography may prove to be a valuable diagnostic tool in the evaluation of the regional vascular supply to the heart in patients with coronary artery disease. 
lary level. In addition, the injection of radiographic contrast agents into the coronary arteries is not without certain risks. Furthermore, it has been the experience of a number of clinicians that some patients with documented angina pectoris and others with myocardial infarctions may have normal coronary arteriograms. One might suspect, therefore, that in these patients alterations in myocardial perfusion may occur at the small vessel level, that is, beyond the resolution of the coronary arteriogram.
To demonstrate regional disturbances in myocardial perfusion, various attempts have been made in recent years to employ radioactive preparations which permit external imaging of the myocardium by the technique of precordial scanning. A number of investigators'-6 have employed radionuclides which concentrate in normal myocardium, such as the radioisotopes of rubidium, cesium, and potassium. While these intravenously injected materials have allowed external imaging of the myocardium, the diagnostic quality of these images has been disappointing.
Other investigators7 8 have injected both diffusible and nondiffusible tracers directly into the coronary arteries at the time of coronary arteriography, designating this procedure the "radionuclide coronary arteriogram." This procedure, unfortunately, requires that the scintillation camera be in the catheterization laboratory, and each view of the heart requires a repeat injection of the radioactive tracer into the coronary artery under study.
Malek and his co-workers9 employed a somewhat different technique in which radioactive-labeled fluorescein derivatives were used to identify damaged regions of the myocardium. This technique, however, has not gained wide favor in this country, possibly because of the wide availability of other methods of determining regional myocardial damage.
Since a significant number of patients with severe coronary artery disease eventually undergo coronary arteriography, we decided to investigate the technique of vascular microembolization with radioactive particles, as is routinely done in human lung perfusion scanning. 10 Although the safety of lung perfusion scanning has been established by its widespread clinical use, it was decided not to extend this technique to the evaluation of regional myocardial perfusion in humans until its safety was first determined in animals. The theoretical usefulness of the myocardial perfusion scan was originally suggested by Quinn and his associates,11 who showed regional reductions in the distribution of 131iodine-labeled macroaggregated serum albumin ( 1311_ MAA) distal to experimentally occluded coronary vessels in dogs. We carried out toxicity studies12 and concluded that there is a wide margin of safety when the number and size of the particles injected into the coronary circulation are carefully controlled. In 17 dogs, in whom the particles were injected directly into the left coronary artery, doses up to approximately 0.02 mg/kg of body weight (i.e., 10 times higher than required for satisfactory imaging) did not significantly alter left ventricular function. No measurable changes in heart rate, left ventricular peakdeveloped and end-diastolic pressures, dp/dt, or in the epicardial electrocardiogram were detected when a standard imaging dose (0.05 mg/ 100 g of LV weight) was injected either into the right or left coronary artery or into both. Good quality images of regional myocardial perfusion were obtained with as little as 0.05 mg/ 100 g of LV weight (approximately 0.002 mg/kg of body weight) of the denatured albumin particles labeled with 99"'1technetium (99MTc) (6-hour physical half-life; 140 kev gamma emission) or 1311 (8-day half-life; 364 kev gamma emission). When particles labeled with two different radionuclides (e.g., 99mTc and 1311 ) were injected into the right and left coronary arteries, respectively, two separate perfusion images could be clearly differentiated by pulse-height discrimination. Injection of a second radionuclide into the same vessel, after Circulation, Volume XLIV, November 1971 one of its branches was temporarily occluded, clearly demonstrated fresh perfusion defects corresponding to the findings observed on the coronary arteriogram.
After the animal studies were completed, our preliminary clinical results following the injection of 99mTc-labeled macroaggregated human serum albumin (0.04 mg., i.e., approximately 0.006 mg/kg of body weight) directly into the left coronary artery of 13 patients undergoing coronary arteriography for the evaluation of coronary artery disease were reported.'13 14 serious untoward reactions to the injection of radiographic contrast material into the coronary arteries were not considered acceptable for this procedure.
No special preparation of the patients was necessary beyond the routine premedication (pentobarbital, 100 mg IM) prior to cardiac catheterization. Atropine (0.9 mg) was routinely administered parenterally prior to coronary arteriography. Left ventricular angiography and coronary arteriography were completed before the injection of radioactive-labeled particles into the coronary circulation.
The left coronary artery was usually injected first. 99mTechnetium-labeled macroaggregated human serum albumin (99mTc-MAA) particles were administered directly through a Sones catheter. The location of the tip of the catheter was verified by fluoroscopy following the injection of a small amount of radiographic contrast material. Each patient received a single handpressure injection of particles in a volume of approximately 0.5 ml (0.04 mg of albumin) diluted with heparinized arterial blood to a volume of 5 ml. Approximately 400,000 particles were injected. The amount of radioactivity per injection varied from 200 to 800 ,uCi, depending on the labeling efficiency for each newly prepared batch of particles. Because of the 6-hour physical half-life of 99mTc, these radioactive particles were freshly prepared each day by a method similar to that reported by Gwyther and Field.16 The method of producing the 99mTc-labeled particles was subsequently modified in order to obtain particles of a more uniform size. Accordingly, 99mTc sulfur colloid macroaggregates, produced by Ficken and associates' method,17 were employed in the last 13 patients. Because of the greater labeling efficiency, only approximately 200,000 particles (0.1 ml) were required to deliver 400 to 800 ,uCi of 99mTc per injection.
After the particles were injected into the left coronary artery, the catheter was flushed with a small amount of contrast material to verify again the location of the catheter tip. Monitoring of the patient's arterial pressure was begun prior to the injection of particles and continued until the arterial catheter was removed. The ECG was monitored continuously both before administration of the particles and for a minimum of 30 minutes following injection during which time the arteriotomy and any other surgical sites were repaired.
Macroaggregated albumin particles labeled with 131I were injected into the right coronary arteries of 12 patients immediately following administration of the 99mTc-labeled particles into the left coronary artery. A single hand-pressure injection of 5 ml of heparinized arterial blood containing 0.1 ml (0.05 mg of albumin) of a commercially supplied 131PIMAA* was made through the coronary artery catheter. Approximately 400,000 particles were injected into the right coronary circulation. The total radioactivity administered varied from 30 to 150 uCi depending on the date of issue of the commercial MAA product (1311 has a half-life of 8 days).
The patients were then transferred to a special canvas-top litter and transported to the Nuclear Medicine Laboratory for radionuclide imaging of the heart. An Anger-type scintillation camerat was used to obtain images of the heart in multiple projections. Routine views included the anterior, left anterior oblique, and left lateral projections when only the left coronary artery was injected. When both coronary arteries were injected, additional views included the right anterior oblique and posterior projections. When two radionuclides (131I and 99mTc) were injected a 1,000-hole "medium-energy" collimator was used for all recordings. When only the 99mTc particles were injected, a 4,000-hole "low-energy" collimator was used.
Separate images were recorded of the radioactive particle distribution derived from injections into the right and left coronary artery, respectively, by the technique of pulse-height discrimination. Thus, with the gamma energy "window" of the scintillation camera set for the photon energy of 1311 (364 kev), images obtained were exclusively related to the small vessel distribution of the 1311-labeled particles previously injected into the right coronary circulation with no contribution from the 99mTc particles previously injected into the left coronary circulation. In a similar manner, adjustment of the gamma energy "window" for the photon energy of 99mTc (140 kev) allowed separate images to be recorded depicting the their greatest dimension. A product which contained any particles or aggregates larger than 100 g was rejected. Visual examinationi of the syriniges containinig the particle suspension was also made immediately prior to dilution with heparinized blood in the catheterization laboratory to ass-ure that gross clumping of the particles lhad not occulrred. Slight agitation of the syringes was performed occasionally to prevent settling of the particles suspended in the sterile saline.
Results
The results of the myocardial perfusion scans, coronary arteriograms, left ventricular angiograms, and ECG along with pertinent clinical data are summarized in table 1 . Representative examples of the myocardial perfusion scans are shown in figures 1 to 8. None of the 29 patients receiving intracoronary artery injections of labeled particles experienced any untoward reactions, as determined by observing the arterial pressure, heart rate, ECG, and general condition. Although occasional premature ventricular contractions were observed immediately after the test injection of radiographic contrast material, no S-T-segment or T-wave alterations or arrhythmias were noted during the injection of the particles or for the period of observation thereafter. None of the patients complained of angina or any other discomfort during or shortly after the injection of particles. Examination of a number of the patients, up to 1 year later (table 2) revealed no evidence to suggest long-term sequelae to the injection of the particles.
In all cases, the radionuclide-myocardial perfusion images were of good quality. to be normal in only seven of the 29 patients. The coronary arteriograms in three of these patients were entirely normal and in the four other patients there were localized narrowings (less than 50% occlusion) of the major branches that were not considered to be significant with respect to total myocardial blood flow. In all other cases, the myocardial perfusion images were considered to be abnormal. In no case in which a coronary artery branch was narrowed more than 75% was a normal radionuclide perfusion pattern observed.
The myocardial perfusion images correlated well with the left ventricular angiograms in that regions of paradoxical wall motion or Circulation, Volume XLlV, November 1971 akynesis were associated with the small vessel which exhibited reduced perfusion on the radionuclide images. In general, the underperfused regions were somewhat smaller than those suggested by the abnormal wall motion in the left ventricular angiograms ( fig. 7) . Similarly, the correlation with radar kymography"'' was good, although the myocardial perfusion images demonstrated myocardial perfusion defects which were usually smaller than those suggested by the extent of abnormal wall motion.
In one case (patient C.P.) an injection of 919m11Tc-labeled particles into the left coronary artery was followed by removal and reinsertion of the Sones catheter into the left arteriography may provide a miore comprehensive description of regional myocardial perfusion than that provided by coronary arteriography alone.
From the small series of patients studied thus far, myocardial perfusion imaging appears to be a promising technique relating to the specific question of the regional distribution of myocardial blood flow. The principle on which this test is based is that 10 to 60 g biodegradable particles injected into the afferent side of any vascular bed will become temporarily lodged in a representatively small number of precapillary or capillary vessels in a distribution which follows the pattern of relative blood flow through the vascular network supplied by the artery injected. Thus, Circulation, Volume XLIV, November 1971 the distribution of these particles labeled with an appropriate radionuclide reflects the distribution of blood flow to each region containing these particles and can be depicted by external radionuclide imaging. Regional obstruction of blood flow is associated with a corresponding area of diminished concentration of radioactivity in the perfusion image. It must be remembered, however, that the apparent distribution is also related to the tissue volumes containing these particles, necessitating multiple views to evaluate adequately their distribution in all regions of the heart. Furthermore, this technique is incapable of measuring total regional myocardial blood flow; only the relative regional distribution of the flow from the particular major vessel receiving the injection can be assessed. figure 4 . The standard comnputer-derived display (left) appears to be enhanced slightly (center) by applying a ".9 point smooth" to the digitally stored data. The apparent margin of the perfusion deficit (arrows) is displayed more sharply (right) by the selection of a degree of contrast enhancement based on the amount of radioactivity present in the normally perfused adjacent region. This display is now independent of photographic variances which often tend to change the apparent size of the perfusion deficit. Since all of the radionuclide images were recorded in a digital format and were ultimately processed by the computer, various methods of handling the data were investigatẽ d in an attempt to improve the quality of the images and to provide a more objective measurement of the anatomic extent of the perfusion deficit. Some of these techniques were quite useful ( fig. 5 ), but others, for example, isometric displays and isocount profiles, tended to be misleading since we were required to display a three-dimensional distribution of radioactivity (corresponding to the relative perfusion per unit volume of The fact that the particles are removed from the myocardial vascular bed with a calculated biological half-time of 3 to 5 hours, as determined by repeated counting over the area of the heart (effective half-time), allows the imaging procedure to be delayed up to several hours from the time of the injection, if necessary. This rate of particle clearance is similar to the rate of clearance of the same type of particles from the pulmonary capillary bed as observed in conventional lung scanning. The mechanism of. removal of these particles is, therefore, probably similar, that is, by the phagocytic activity of circulating macrophages.
The ultimate clinical diagnostic value of myocardial perfusion imaging will have to await further experience. In the series of patients studied thus far, the quality of the perfusion images has suggested that this procedure may provide important additional information concerning altered patterns of regional primary and collateral perfusion. Myocardial perfusion imaging in conjunction with coronary arteriography may find application in the selection of suitable candidates for coronary bypass or other revascularization procedures. In the postoperative evaluation of these patients, the combination of coronary arteriography and perfusion imaging following selective injection directly into the graft may provide a highly accurate picture of the changes resulting from surgery. This may be particularly helpful in the case of internal mammary implantation where the distribution of the labeled particles may define the extent of revascularization at the small vessel level better than arteriography alone. This procedure may also prove to be valuable in the examination of patients presenting with angina in whom the conventional coronary arteriogram is normal although a regional perfusion abnormality still remains a possibility.
From the investigative point of view, myocardial perfusion imaging, using the double-label technique, may be advantageous in studying the effects of various drugs on regional myocardial perfusion patterns in patients with regional perfusion abnormalities. In this case, particles labeled with one radionuclide are introduced into the coronary circulation followed by the administration of the drug. This, in turn, is followed by the injection of particles labeled with a different radionuclide into the same vessel; the differences in perfusion distribution then can be noted from the perfusion images. Such investigations are currently under way in our laboratories.
